key: cord-0949802-skc0e5ra
authors: Patel, Viren; Sarwer, David B; Bartlett, Scott P
title: Commentary on: A Randomized, Single-Blind, Crossover Study Evaluating the Impact of OnabotulinumtoxinA Treatment on Mood and Appearance During the COVID-19 Pandemic
date: 2021-04-09
journal: Aesthet Surg J
DOI: 10.1093/asj/sjab180
sha: 333f690eeb09d5034e175cd23d6e253229366613
doc_id: 949802
cord_uid: skc0e5ra

nan

groups was assessed using the FACE-Q and subject happiness scale. 1, 2 The placebo group was eventually provided treatment and re-administered the same study instruments. 3 The results of the study are not wholly surprising: patients who were in the placebo group demonstrated no changes in quality of life or happiness, while patients in the treatment arm reported improvements in both. Subsequently, patients in the placebo group demonstrated similar improvements in quality of life and happiness after they received treatment. 3 This result, in it of itself, is not novel, as multiple studies have shown increased patient satisfaction after Botox injections in the upper third of the face. For example, Chang et al, in a cohort of 57 female patients, found satisfaction increased by 28%, also assessed by the FACE-Q. 4 Similarly, in a different study, patients treated with onabotulinumtoxinA reported significantly higher satisfaction than patients treated with placebo, regardless of patient age. 5 The unique aspect of the current study is the use of a sample novelty of patients who receive regular neurotoxin injections but may "have exceeded their normal treatment interval" as a result of shutdowns during the pandemic. However, the only criterion for inclusion in the study prior neurotoxin treatment at least 20 weeks before enrollment. While this may have captured the aforementioned target population, could this could also include patients with remote history of neurotoxin treatment, for whom the pandemic had no effect? Thus, the interpretation of the results in light of practice changes related to the pandemic must be interpreted cautiously.

Furthermore, while the authors partially tie this study to the pandemic, they fail to truly delve into this aspect in their discussion, outside of suggesting how appearance of the upper third of the face has likely gained increased importance during the pandemic, when most Americans have adopted the practice of wearing masks in public. While this intuitively makes sense, the study design does not We began exploring how the COVID-19 pandemic, and specifically mask usage, affected perceptions of beauty in the first 6 months of the pandemic. 6 We found that, in general, most faces were rated as more attractive when a mask was worn. More specifically, faces which were judged to be less attractive at baseline demonstrated the greatest improvements in perceived attractiveness, while attractive faces were rated no differently when wearing a mask. The study raised many important questions about how mask usage disrupted normal assessments of facial beauty. The periorbital region has often been tabbed to be what defines beauty, but our results suggested harmony between facial aspects was the most important. 6, 7 If disharmonious aspects of the face were covered by the mask, like the perioral region or the jaw, perceived attractiveness of masked faces would increase, also suggesting increased importance of the visible upper third of the face. Taken together, this could suggest patients receiving neurotoxin treatment for forehead wrinkles, as in this study, would experience greater improvements in perceived attractiveness while wearing a mask than would patients whose full face was visible.

The current study also brings into question how paralyzing the facial muscles of the upper third of the face may affect perceptions of emotions. As the authors mention in their discussion, the upper face is crucial to expressing "anger, sadness and fear" whereas the perioral region is critical for expressing happiness. 8 With seemingly reduced ability to express these negative emotions, were patients in the study perceived to be more positive on the whole? Additionally, were there any drawbacks of this, including miscommunication of negative emotions, with visual clues from the bottom half the face being obscured by a mask and reduced expression from the upper third of the face? Both issues should be part of the informed decision-making process between patients and aesthetic providers.

Overall, this study further contributes to the growing body of literature examining how patients have been affected by this pandemic. Moreover, it is important for aesthetic surgeons to be aware of how mask usage affects patients seeking cosmetic treatments of the face, especially with masks seeming to be an enduring fixture of interpersonal interactions for the near future. We hope that studies like this inspire further investigations into ways this pandemic has affected perceptions of attractiveness and emotion.

Measuring patient-reported outcomes in facial aesthetic patients: development of the FACE-Q

A measure of subjective happiness: Preliminary reliability and construct validation

Crossover Study Evaluating the Impact of OnabotulinumtoxinA Treatment on Mood and Appearance During the COVID-19 Pandemic

Patient Perceived Benefit in Facial Aesthetic Procedures: FACE-Q as a Tool to Study Botulinum Toxin Injection Outcomes

Patient-Reported Outcomes, and Safety for

Millennial Subjects Treated With OnabotulinumtoxinA for Moderate to Severe Horizontal Forehead Lines

Ideal Facial Relationships and Goals

Judgments of facial attractiveness as a combination of facial parts information over time: Social and aesthetic factors

The psychological impact of quarantine and how to reduce it: rapid review of the evidence. The Lancet

A c c e p t e d M a n u s c r i p t